PP
BSX icon

Paloma Partners’s Boston Scientific BSX Stock Holding History

Paloma Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$7.7K – 1191
2024
Q2 		$7.7K Buy
+100
New +$7.32K ﹤0.01% 1209
2016
Q3 		– Sell
-40,000
Closed -$935K – 1847
2016
Q2 		$935K Hold
40,000
– – 0.01% 1204
2016
Q1 		$752K Buy
+40,000
New +$703K 0.01% 1067

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paloma Partners's BSX Position: Q4 2024 in Review

Paloma Partners sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 16,273 shares — an estimated $1.36M sold.

Paloma Partners first reported a position in BSX in Q2 2013 and held it in 29 quarters. The position peaked at $6.29M in Q4 2020. 1,512 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

  • Paloma Partners reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 16,273 Boston Scientific shares in Q4 2024, an estimated $1.36M.
  • Paloma Partners first reported a position in Boston Scientific in Q2 2013 and held it in 29 quarters.
  • Paloma Partners's Boston Scientific position peaked at $6.29M in Q4 2020.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.